BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Long Term Debt

Aspire Biopharma Holdings's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Aspire Biopharma Holdings Long Term Debt History

Loading

Aspire Biopharma Holdings vs. peers: Long Term Debt Comparison

Loading

Aspire Biopharma Holdings Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aspire Biopharma Holdings (ASBP) FAQ

Aspire Biopharma Holdings (ASBP) currently reports a long-term debt of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Aspire Biopharma Holdings's long-term debt history and peer comparisons.

Aspire Biopharma Holdings's long-term debt changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $0 in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.